Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history as the latest entry, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:35:40.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study title now specifies Etentamig (ABBV-383) for intravenous use in adults with relapsed or refractory multiple myeloma, with related sections added or updated accordingly.
    Difference
    0.6%
    Check dated 2026-02-18T16:27:40.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    New entry 'Revision: v3.4.2' was added to the record history. A general government operating status notice was removed from deletions.
    Difference
    0.4%
    Check dated 2026-02-11T12:34:29.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page history shows a site-wide notice about a lapse in government funding and operation status, and an update from Revision: v3.4.0 to v3.4.1; no substantive changes to the study record content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:53:39.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The history page now uses color-coded highlights to differentiate additions and deletions and includes a revision notice (v3.4.0). A glossary toggle to show glossary terms has been added.
    Difference
    0.6%
    Check dated 2026-01-28T04:28:32.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The record history shows a new revision entry (v3.3.4) added and a previous revision (v3.3.3) removed; these are minor metadata updates to the version history and do not affect core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:07:42.000Z thumbnail image

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.